Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia-oculomotor apraxia 4 and pilocytic astrocytoma

Ataxia-oculomotor apraxia type 4 (AOA4) is a rare autosomal recessive neurologic disorder. The phenotype is characterized by ataxia, oculomotor apraxia, peripheral neuropathy and dystonia. AOA4 is caused by biallelic pathogenic variants in the PNKP gene encoding a polynucleotide kinase 3′-phosphatas...

Full description

Saved in:
Bibliographic Details
Main Authors: Scholz, Christian (Author) , Golas, M. M. (Author) , Weber, R. G. (Author) , Hartmann, C. (Author) , Lehmann, U. (Author) , Sahm, Felix (Author) , Schmidt, G. (Author) , Auber, B. (Author) , Sturm, M. (Author) , Schlegelberger, B. (Author) , Illig, T. (Author) , Steinemann, D. (Author) , Hofmann, W. (Author)
Format: Article (Journal) Editorial
Language:English
Published: 2 March 2018
In: Clinical genetics
Year: 2018, Volume: 94, Issue: 1, Pages: 185-186
ISSN:1399-0004
DOI:10.1111/cge.13216
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/cge.13216
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/cge.13216
Get full text
Author Notes:C. Scholz, M.M. Golas, R.G. Weber, C. Hartmann, U. Lehmann, F. Sahm, G. Schmidt, B. Auber, M. Sturm, B. Schlegelberger, T. Illig, D. Steinemann, W. Hofmann
Description
Summary:Ataxia-oculomotor apraxia type 4 (AOA4) is a rare autosomal recessive neurologic disorder. The phenotype is characterized by ataxia, oculomotor apraxia, peripheral neuropathy and dystonia. AOA4 is caused by biallelic pathogenic variants in the PNKP gene encoding a polynucleotide kinase 3′-phosphatase with an important function in DNA-damage repair. By whole exome sequencing, we identified 2 variants within the PNKP gene in a 27-year-old German woman with a clinical AOA phenotype combined with a cerebellar pilocytic astrocytoma diagnosed at 23 years of age. One variant, a duplication in exon 14 resulting in the frameshift c.1253_1269dup p.(Thr424fs*49), has previously been described as pathogenic, for example, in cases of AOA4. The second variant, representing a nonsense mutation in exon 17, c.1545C>G p.(Tyr515*), has not yet been described and is predicted to cause a loss of the 7 C-terminal amino acids. This is the first description of AOA4 in a patient with central European descent. Furthermore, the occurrence of a pilocytic astrocytoma has not been described before in an AOA4 patient. Our data demonstrate compound heterozygous PNKP germline variants in a German patient with AOA4 and provide evidence for a possible link with tumor predisposition. Localization of the 2 variants in human PNKP NP_009185.2. NM_007254.3:c.1253_1269dup p.(Thr424fs*49) is predicted to cause a frameshift within the kinase domain, NM_007254.3:c.1545C>G p.(Tyr515*) is predicted to cause loss of 2 C-terminal amino acids of the kinase domain and 5 additional C-terminal amino acids.
Item Description:Gesehen am 22.04.2020
Physical Description:Online Resource
ISSN:1399-0004
DOI:10.1111/cge.13216